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Abstract Hydrogen peroxide is an important regu-
lator of protein tyrosine phosphatase activity via
reversible oxidation. However, the role of iron in this
reaction has not been yet elucidated. Here we compare
the influence of hydrogen peroxide and the ferrous
iron (reagent for Fenton reaction) on the enzymatic
activity of recombinant CD45, LAR, PTP1B phos-
phatases and cellular CD45 in Jurkat cells. The
obtained results show that ferrous iron (II) is potent
inhibitor of CD45, LAR and PTP1B, but the inhibitory
effect is concentration dependent. We found that the
higher concentrations of ferrous iron (II) increase the
inactivation of CD45, LAR and PTP1B phosphatase
caused by hydrogen peroxide, but the addition of the
physiological concentration (500 nM) of ferrous
iron (II) has even a slightly preventive effect on the
phosphatase activity against hydrogen peroxide.
Keywords Ferrous iron  Hydrogen peroxide 
CD45  LAR  PTP1B
Introduction
Protein tyrosine phosphatases (PTPs) are responsible
for the regulation of tyrosine phosphorylation status
controlling numerous cellular processes, such as
cellular growth, differentiation, metabolism, cell–cell
communication and immune response (Tonks 2006).
One of the key representatives of PTPs is CD45, which
controls many cellular processes and its overactivity is
involved in autoimmune disorders, allergic response
and carcinogenesis (Hermiston et al. 2009; Tan et al.
2000; Dios et al. 2005; Huntington and Tarlington
2004). CD45 is abundantly expressed in the Jurkat cell
line (Zamoyska 2007). Phosphatases PTP1B is
involved in pathogenesis of type 2 diabetes and
obesity (Bence et al. 2006) and is a target in breast
cancer treatment (Aceto and Bentires-Alj 2012). LAR
phosphatase have also been implicated in metabolic
regulation and cancer (Chagnon et al. 2004). CD45
and LAR are receptor-like PTPs predominantly found
in the plasma membrane, while PTP1B is intracellular
(cytosolic) phosphatase localized in a variety of
intracellular compartments, such as cytosol, plasma
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membrane or endoplasmic reticulum (Andersen et al.
2001).
The hallmark defining the PTP superfamily is the
strictly conserved active site sequence C(X)5R within
the catalytic domain, which constitutes the phos-
phate-binding pocket of the enzyme (Tabernero et al.
2008). The cysteine residue inside the signature motif
exists in the thiolate anion form, and is highly prone
to oxidation (Pagliarini et al. 2004). Oxidation of the
cysteine residue leads to the formation of a reversible
form of sulfenic acid residue, while a highly
oxidizing environment can induce further oxidation
yielding physiologically irreversible sulfinic and
sulfonic acid residues, all of which consequently
cause inactivation of the enzyme (Ostman et al.
2011). Oxidative stress, defined as excessive reactive
oxygen species (ROS) formation, may induce inac-
tivation of protein tyrosine phosphatases. Inactivation
via oxidation was suggested as a mechanism of
protein tyrosine phosphatases regulation (Persson
et al. 2004).
A unique biochemical and structural characteristic
of the PTPs catalytic cysteine engendered a hypothesis
that these enzymes might be direct targets of ROS
chemistry. Many PTPs are shown to be oxidized
transiently in response to various cellular stimuli. ROS
such as hydrogen peroxide, function as second mes-
sengers and can regulate tyrosine phosphorylation-
mediated signaling pathways (Finkel 2003).
Moreover, hydrogen peroxide may undergo spon-
taneous or enzymatic conversion to more potent
oxidants (Klenk et al. 2000). We have recently
identified that hydrogen peroxide, in the presence of
carboxylic acids, efficiently activated to form peroxy
acid, can induces inactivation of PTPs (Kuban-
Jankowska et al. 2012, 2015; Bhattacharya et al.
2008). Due to the ubiquity of iron ions, hydrogen
peroxide can lead to generation of highly reactive
radicals such as hydroxyl radical during UV light
exposure or by Fenton reaction in the presence of
ferrous iron (II) (Winterbourn 2008). The Fenton
reaction generally occurs in chemical and biological
systems, but the nature of the oxidizing species
obtained in a reaction observed by H.J.H. Fenton
over one hundred years ago, is still not well
understood (Barbusinski 2009). It was found as a
key reaction in the oxidation of membrane lipids or
amino acids. Importantly, the Fenton reaction is
supposed to be involved in heart diseases, such as
ischemia and reperfusion (Prousek 1995). In the
Fenton reaction ferrous iron (II) is oxidized by
hydrogen peroxide to ferric iron (III), a hydroxyl
radical, and a hydroxyl anion (Fig. 1a). Hydrogen
peroxide produced upon activation of many cell
surface receptors is considered as a major regulator
of PTPs in biological systems, but hydroxyl radical
was also hypothesized to be physiologically relevant
inhibitor of PTP1B phosphatase (Meng and Zhang
2013). Moreover, the intracellular iron after treat-
ment with ROS may alters the signal transduction
pathways (Deb et al. 2009).
Interestingly, the cysteine residue, which is essen-
tial for PTPs activity, is regarded as a main target for
the hydroxyl radical. Comparison of the kinetic data
for reactions of the hydroxyl radical with different
amino acids (Fig. 1b), allows us an observation of
the difference in oxidation. Although the variation in
the rate constants is relatively small, the aromatic and
sulfur-containing amino acids would be expected to
be damaged more rapidly with the highest selectivity
to cysteine residue (Davies 2005). Does selective
diversity of the hydroxyl radical in biological
systems (including PTPs) really exist? The high
reactivity of hydroxyl radical is supposed to limit its
ability to diffuse and cause active site—specific
inactivation.
Hydrogen peroxide may relatively easily cross the
cell membrane in response to insulin or epidermal
growth factor, and control the cellular activity of
protein tyrosine phosphatases therein (Rhee et al.
2000). Hydrogen peroxide is able to oxidize the
catalytic cysteine residue to sulfenic acid, which can
be reversibly reduced by various cellular reducing
agents (Goldstein et al. 2005). The effect of hydrogen
peroxide on activity of PTPs was already studied and
described (Ross et al. 2007; Chiarugi and Cirri 2003).
But the effect of the presence of ferrous iron (II),
physiologically relevant reagent, was not been yet
elucidated. The trace amounts of iron are presented in
many cells. The potentially toxic labile iron exists in
cells as a transit pool known as labile iron pool (LIP).
It was estimated that the physiological concentration
of LIP in Jurkat cells is around 3 ± 0.5 lM and that
the treatment with hydrogen peroxide increased the
cytosolic LIP levels (Al-Qenaei et al. 2014). Other
studies showed that the estimated values of LIP for
resting erythroid and myeloid cells are in the range of
0.2–1.5 lM (Epsztejn et al. 1997). Here we decided to
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compare the impact of hydrogen peroxide on recom-
binant phosphatases CD45, LAR, PTP1B and cellular
CD45 from Jurkat cells in presence and in absence of
ferrous iron at concentrations close to physiological.
Materials and methods
Cell line and cell culture
The human Jurkat T cell line, clone E.6-1, was
obtained from European Collection of Cell Culture
(ECACC, UK). The cells were cultured at 37 C in
RPMI 1640 medium supplemented with 10 % fetal
bovine serum, 100 lg/mL penicillin/streptomycin and
2 mM L-glutamine. The culture was maintained at
37 C and in an atmosphere containing 5 % CO2.
RPMI 1640 medium and supplements were obtained
from Sigma–Aldrich. The cell culture density was kept
at 1 9 106 cells/mL. At least every two days the
medium was replaced with the fresh one, and the cells
were counted and reseeded to maintain the recom-
mended density. Concentration of protein in Jurkat
cell lysate was measured using the Bradford colori-
metric method. The Bradford method is based on
Coomassie Brilliant Blue G-250 absorbance shift in
the presence of protein. Binding to the protein being
assayed under acidic conditions, the red dye is
converted into the blue derivative. The amount of
protein in the sample is proportional to the amount of
bound dye, and thus to increase of an absorbance at
595 nm. Based on prepared standard concentrations of
bovine serum albumin, concentration of protein in
samples was calculated. Cells were suspended in FBS
free RPMI 1640 medium before treatment with
inhibitors.
Cell viability assay with MTT
The Jurkat cells (1 9 106 cells/mL) untreated (con-
trol) or treated with solution of hydrogen peroxide,
FeSO4, or hydrogen peroxide together with FeSO4
(Fenton reaction) after the appropriate incubation time
were suspended in solution of 0.5 mg/mL MTT(3-
[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium
bromide) in RPMI 1640 without phenol red. The 100
lL samples were incubated for 2–4 h at 37 C in
96-well plates. When the purple precipitate was
clearly visible under the microscope, 100 lL of
DMSO was added to each well and the plate with
cover was left in the dark for 2–4 h. The absorbance at
540 nM was determined using a microplate reader.
Determination of PTP CD45 activity in cell lysate
The Jurkat cells (density at 1 9 106 cells/mL) were
untreated (control) or treated with solution of hydro-
gen peroxide, FeSO4, or hydrogen peroxide together
with FeSO4 (Fenton reaction) and incubated for 1 h at
37 C in 24-well plates. The cells were rinsed twice
with TBS, suspended at the density of 1 9 107 cells/
mL in Lysis buffer pH 7.4 with 0.5 % NP-40, 25 lg/
mL leupeptin, 25 lg/mL pepstatin, 2 lg/mL apro-
tinin, 1 mM PMSF, vortexed briefly and placed on ice
for 15 min. The cells were then solubilized by forcing
the lysates through a 19-gauge needle (0.686 mm
inner diameter) 20 times and centrifuged at
120009g at 4 C for 5 min. The supernatants were
transferred to test tubes and assayed immediately. The
day prior to the assay, the 96-well microplates were
coated with CD45 capture antibodies (8 lg/mL in
PBS) and incubated overnight at room temperature.
After washing the wells, cell lysate was added, and the
Fig. 1 Hydrogen peroxide
and ferrous iron in Fenton
reaction chemistry.
a Ferrous iron (II) is
oxidized by hydrogen
peroxide to ferric iron (III)
and hydroxyl radical. b Rate
constants for the reaction of
hydroxyl radical with
selected amino acids at pH 7
(Davies 2005)
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plate was placed on a rocking platform at 30 rpm for
3 h at room temperature. Lysates were aspirated from
the wells and PTP activity was measured colorimet-
rically using 200 lM tyrosine phosphate specific
substrate (phosphopeptide DADEY(PO3)LIPQQG in
10 mM HEPES buffer pH 7.4) and malachite green.
The phosphopeptide substrate was dephosphorylated
by active CD45 to generate unphosphorylated peptide
and free phosphate. The free phosphate was then
detected by a sensitive dye binding assay using
malachite green and molybdic acid. The increase in
absorbance at 620 nM was measured with the
microplate reader. The activity of CD45 was deter-
mined by calculating the rate of phosphate release.
CD45 capture antibody, tyrosine phosphate substrate
DADEY(PO3)LIPQQG, malachite green and molyb-
dic acid were purchased from R&D Systems. Deter-
gent NP-40, protease inhibitors (leupeptin, pepstatin,
aprotinin) and phenylmethylsulfonylfluoride (PMSF)
were purchased from Sigma–Aldrich.
Recombinant CD45, LAR and PTP1B activity
assay
Human recombinant CD45 protein tyrosine phos-
phatase (PTP catalytic domain) was obtained from
Sigma–Aldrich. Human LAR phosphatase (PTP cat-
alytic domain) was obtained from Calbiochem.
Human PTP1B phosphatase was purchased from
Prospec. The solution of the recombinant protein
tyrosine phosphatase CD45, LAR and PTP1B was
prepared in 10 mM HEPES buffer pH 7.4. The final
concentration of phospahatses in reaction samples was
0.8 lg/mL (10 nM). The CD45, LAR and PTP1B
enzymes was untreated (control) or treated with
solution of hydrogen peroxide, FeSO4, or hydrogen
peroxide together with FeSO4 in different concentra-
tions and) in the presence or absence of 1 mM EDTA.
The assay was performed in 96-well microplates, and
the final volume of each sample was 200 lL. The
enzymatic activity of CD45, LAR and PTP1B was
measured using 1 mM chromogenic substrate para-
nitrophenyl phosphate (pNPP) in 10 mM HEPES
buffer pH 7.4, at 37 C. Phosphatase hydrolyzed
pNPP to para-nitrophenol and inorganic phosphate.
Para-nitrophenol is an intensely yellow colored
soluble product under alkaline conditions. The
increase in absorbance (due to para-nitrophenol
formation) is linearly proportional to enzymatic
activity concentration (with excessive substrate, i.e.
zero-order kinetics) and was assessed at 405 nM on a
microplate reader Jupiter (Biogenet) using DigiRead
Communication Software (Asys Hitech GmbH).
NBD-Cl modification assay
Sulfenic acid-labeling reagent 7-chloro-2-nitrobenzo-
2-oxa-1,3-diazole (NBD-Cl) was purchased from
Sigma. NDB-Cl react with both sulfenic acid and
thiols forming adducts with different spectra. The
amount of modified CD45, LAR, PTP1B thiol adduct
with NBD (Cys-S-NBD adduct) was measured after
30 min incubation with NDB-Cl (0.6 mM in a 0.5 mL
of sample) as absorbance in 347 and 420 nM with
spectrophotometer.
Statistical analysis
The experiments were performed at least three times.
The data were applied and analyzed with GraphPad
Prism (GraphPad Software v.4). Statistical analyses
were performed using ANOVA combined with
Tukey’s test, or t test. The data were expressed as
mean ± SD. Differences between means were con-
sidered significant for P\ 0.05.
Results
To asses the effect of ferrous iron (II) and hydrogen
peroxide we measured the enzymatic activity of
recombinant CD45, LAR and PTP1B phosphatases
under the cell-free conditions and CD45 phosphatase
in Jurkat cells. The enzymes and cells were treated
with solution of hydrogen peroxide, iron (II) sulfate, or
both solutions together in different concentrations.
Iron (II) sulfate (FeSO4) in aqueous solutions under-
goes dissociation to ferrous iron (II) and sulfate ion
(SO4
2-).
Comparison of the effect of hydrogen peroxide
and ferrous iron on activity of recombinant CD45
phosphatase
In first step we decided to assess the effect of different
concentrations of hydrogen peroxide on enzymatic
activity of recombinant CD45 (data not shown) for
calculation of IC50 value to plan the range of
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concentrations of hydrogen peroxide to be used in our
studies. We calculated IC50 value for hydrogen
peroxide as 8 lM, which is compatible with previous
literature (Groen et al. 2005; Rider et al. 2003).
Then we compared the effect of hydrogen peroxide
with ferrous iron (II) and we found that hydrogen
peroxide induces inactivation of recombinant CD45
more effectively than in the presence of physiological
concentration of ferrous iron (II). We observed that
5 lM hydrogen peroxide after 15 min of incubation
inhibited 24 % of CD45 activity as compared to the
control. The same concentration of hydrogen peroxide
added together with 500 nM iron (II) sulfate decreased
CD45 activity by 10 % (Fig. 2a). Incubation of
recombinant phosphatase with solution of 500 nM
iron (II) sulfate had virtually no effect on enzymatic
activity (Fig. 1a). We tested the enzymatic activity of
CD45 under the cell-free conditions in the presence
and absence of 1 mM EDTA, but no statistically
significant differences were observed between the
activity of phosphatase treated with solution of
hydrogen peroxide, iron (II) sulfate or Fenton’s
reagent in the presence or absence of EDTA (Fig. 2b).
Effect of ferrous iron on CD45 in Jurkat cells
The differences between the effect of hydrogen
peroxide and the Fenton reaction were observed also
for the CD45 activity assay in Jurkat cells. After 1 h of
treatment of the cells with 10 lM hydrogen peroxide,
13 % of CD45 activity was inhibited, while incubation
with the same concentration of hydrogen peroxide but
in the presence of 2 lM iron (II) sulfate, decreased
enzyme activity by 7 % (Fig. 3a). A solution of 2 lM
iron (II) sulfate induces 5 % loss of CD45 activity in
comparison to the control. Fenton’s reagent in the
presence of EDTA more strongly reduced the enzy-
matic activity of CD45 than in the absence of EDTA
(Fig. 3a). The effect on enzyme activity of Fenton’s
reagent in the presence of EDTA (12 %) was similar to
the effect of hydrogen peroxide (13 %).
The cell viability after 1 h of treatment of Jurkat
cells with 10 lM hydrogen peroxide was not signif-
icantly changed (98 %), whereas the effect of the
Fenton reaction on cell viability was slightly higher
(92 %) (Fig. 3b).
Effect of ferrous iron and hydrogen peroxide
on recombinant phosphatase CD45, LAR
and PTP1B
We treated CD45, LAR and PTP1B recombinant
phosphatase with different concentrations (0.5; 2;
20 lM) of iron sulfate combined with different
concentrations of hydrogen peroxide (5; 10; 20 lM).
The selected concentrations are presented in a
Fig. 4a, b.
Fig. 2 Recombinant CD45 inactivation mediated by hydrogen
peroxide and ferrous iron. a CD45 activity after treatment with
5 lM hydrogen peroxide, 0.5 lM FeSO4 or hydrogen peroxide
together with FeSO4 in presence of 1 mM pNPP. Data are
presented as a mean ± SD (n = 3). One-way analysis of
variance combined with Tukey test. b EDTA has no impact
on enzymatic activity of recombinant CD45. The effect of
presence of 1 mM EDTA on the activity of recombinant CD45
after 15 min incubation with 5 lM hydrogen peroxide, 0.5 lM
FeSO4 or hydrogen peroxide together with FeSO4 (Fenton’s
reagent). The results were presented as a percentage of control.
Data presented as a means from three separate experiments.
*Significantly different from control (P\ 0.01) **Means were
not significantly different in pairs (analyzed with t test,
P[ 0.05)
Biometals (2015) 28:975–986 979
123
We demonstrated that both the hydrogen peroxide
and ferrous iron (II) induce the inactivation of
recombinant CD45, LAR and PTP1B and that the
inhibitory effect was concentration dependent. Incu-
bation of recombinant phosphatases with solution of
20 lM iron (II) sulfate significantly lowered the
enzymatic activity, while 500 nM iron (II) sulfate
had virtually no effect on enzymatic activity (Fig. 4a).
We observed also difference in the inactivation
level between the phosphatases. PTP1B was consid-
erably more sensitive for higher concentrations of iron
(II) sulfate than hydrogen peroxide, while it was
conversely for CD45 (Fig. 4a). We found that 20 lM
iron (II) sulfate increased the effect of hydrogen
peroxide on enzymatic activity of PTP1B. Interest-
ingly, in our studies, we discovered that the low
concentration (500 nM) of iron (II) sulfate decreases
the inhibitory effect of hydrogen peroxide, paradox-
ically preventing PTPs from inactivation by hydrogen
peroxide (Fig. 4a).
To examine the oxidation status of cysteine
residues in studied PTPs we performed the thiol-
labeling assay with NBD-Cl. We have measured the
amount of NBD-Cl adducts with CD45, LAR and
PTP1B thiol groups. As observed for CD45 and LAR
phosphatase the amount of non-oxidized thiol groups
was lower after treatment with hydrogen peroxide
comparing to control and iron (II) sulfate and was
increasing in addition of ferrous iron (Fig. 4b). The
amount of non-oxidized thiol groups in PTP1B was
lower after treatment with iron (II) sulfate than
control and hydrogen peroxide. Moreover, the
inhibitory effect of hydrogen peroxide in presence
of iron (II) sulfate was significantly enhanced
(Fig. 4b).
Electrostatic potential of CD45, LAR and PTP1B
active sites analysis
In order to determine if the ferrous iron is able to
penetrate into the active sites of CD45, LAR and
PTP1B we decided to analyze the electrostatic surface
of the phosphatase catalytic domains. The computa-
tional study showed that the surface of the active site
of CD45 is highly electropositive and there are amino
acids residues (Arg834, His797, Lys736) with positive
Fig. 3 Impact of ferrous iron and hydrogen peroxide on the
enzymatic activity of CD45 and cell viability in Jurkat cells.
a The inhibitory effect of 10 lM hydrogen peroxide, 2 lM
FeSO4 or hydrogen peroxide together with FeSO4 and with
1 mM EDTA on enzymatic activity of CD45 after treatment of
Jurkat cells for 1 h. The results were presented as a percentage
of inhibited activity comparing to control (as 0 %). Data
presented as a mean ± SD (n = 3 independent experiments).
One-way analysis of variance combined with Tukey test.
*Significantly different (P\ 0.001) from control. **Signifi-
cantly different (P\ 0.05). b Jurkat cells viability after
treatment with 10 lM hydrogen peroxide, 2 lM FeSO4 or
hydrogen peroxide together with FeSO4 or 1 mM EDTA for 1 h
measured with MTT assay. The results were presented as a
percentage of control. Data presented as a mean ± SD (n = 3).
One-way analysis of variance combined with Tukey test.
*Significantly different (P\ 0.01) from control
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charge limiting access to the catalytic cysteine
(Fig. 5a). This suggests that the electrostatic repulsion
partially prevents ferrous iron (II) from entering into
the catalytic center of CD45, whereas hydrogen
peroxide may easily penetrate into the catalytic
cysteine inducing its oxidation.
Fig. 4 Impact of ferrous iron and hydrogen peroxide on the
enzymatic activity of recombinant CD45, LAR, PTP1B
phosphatases. a The inhibitory effect of 0.5, 2, 20 lM FeSO4,
5, 10, 20 lM hydrogen peroxide or hydrogen peroxide together
with FeSO4 on recombinant CD45, LAR and PTP1B after
15 min of incubation. The results were presented as a
percentage of inhibited activity comparing to control (as 0 %).
Data presented as a mean ± SD (n = 3). b The amount of
modified CD45, LAR, PTP1B thiol adduct with NBD (Cys-S-
NBD adduct) as absorbance in 420 nm. One-way analysis of
variance combined with Tukey test. *Significantly different
(P\ 0.05) from control. **Significantly different (P\ 0.001)
Biometals (2015) 28:975–986 981
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The similar electrostatic potential calculations
were performed for the active sites of LAR and
PTP1B. We showed that the surface of LAR and
PTP1B active sites are largely positively charged
and there are only slight differences found
between surfaces of active site surrounding
(Fig. 5b, c).
Discussion
Here we showed that ferrous iron (II) can induce
inactivation of recombinant CD45, LAR, PTP1B and
cellular CD45 phosphatase in Jurkat cells. We found
that the effect of ferrous iron (II) was concentration
dependent.
Fig. 5 Positively charged catalytic pocket of tyrosine phos-
phatase CD45, LAR, PTP1B. a The ribbon representation of the
D1 domain from tyrosine phosphatase CD45, LAR and PTP1B.
b The Van der Waals surface of D1 domain from the CD45,
LAR, PTP1B receptor protein colored according to the surface
potential, calculated using APBS (Baker et al. 2001). Blue
indicates positive while red negative charge. Catalytic Cys828,
His797 and two neighboring positively charged residues Lys736
and Arg834 are marked in sticks. The same protein orientations
are in a and b, in b white dotted square corresponds to the black
square in a and indicates the entrance to the catalytic center.
Protein coordinates for CD45 were taken from PDB 2YGU from
Glu599 to Gly891. All seleno-methionines were replaced by
methionines and Ser828 was replaced by cysteine. Protein
coordinates for LAR were taken from PDB 1LAR and for
PTP1B from PDB 1SUG. (Color figure online)
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We demonstrate that the physiological concentra-
tions of ferrous iron (II) has lower inhibitory effect on
CD45, LAR and PTP1B phosphatase than hydrogen
peroxide. Moreover, in our studies, the addition of low
concentration of ferrous iron to hydrogen peroxide
paradoxically exhibits a slightly preventive effect.
We suggest that stronger effect of low concentra-
tions of hydrogen peroxide is due to the fact it may
easily penetrate to PTP active site inducing inactiva-
tion of enzymatic activity, while small amounts of
ferrous iron are not able to reach the PTPs active site
(Fig. 6). Computational analysis of the CD45, LAR
and PTP1B active sites allowed us to assume that the
electropositive surface of the active site residues can
cause repulsion of positively charged ferrous iron
(Fig. 5). Presumably, higher concentrations of ferrous
iron allow it to place closer to the active site of PTPs
and induce inactivation. Preventive effect of low
concentrations of ferrous iron on the phosphatase
activity against hydrogen peroxide may be explained
due to the removal of hydrogen peroxide from the
reaction environment by absorbing hydrogen peroxide
into Fenton reaction (Fig. 6). Highly reactive hydroxyl
radical, formed in Fenton reaction, is only able to
cause unspecific damage and will not reach the
catalytic cysteine in the active site.
The weaker effect of low concentrations of ferrous
iron (II) than hydrogen peroxide was observed also for
CD45 phosphatase in Jurkat cells (Fig. 3a). We
suggest that ferrous iron (II) due to electrostatic
potential of PTPs active site, is not able to reach the
intracellular target, while hydrogen peroxide would
easily cross the cell membrane of Jurkat cells and
penetrate to PTP active site inducing inactivation of
enzymatic activity. The fact that the impact of ferrous
iron with hydrogen peroxide in the presence of EDTA
in Jurkat cells was similar to the effect of hydrogen
peroxide confirmed the paradoxically protective role
of the low amounts of ferrous iron on the activity of
phosphatase CD45. EDTA has virtually no impact on
the enzymatic activity of recombinant CD45 (Fig. 2b),
but enhances the inhibitory effect of hydrogen perox-
ide in presence of ferrous iron in Jurkat cells, probably
by chelating the extracellular ferrous iron derived
from the cell treatment and allowing free penetration
by hydrogen peroxide. The other explanation may be
the formation of iron chelate complex (FeEDTA)
leading to the initiation of other strong oxidants or
lipid peroxidation (Bucher et al. 1983a, b) and
consequently to the oxidation of CD45 phosphatase
(Conrad et al. 2010).
We found that addition of ferrous iron (II) to
hydrogen peroxide has slightly decreases the viability
of Jurkat cells (Fig. 3b). Further studies are required to
investigate this problem. The hydroxyl radical form
from hydrogen peroxide in presence of ferrous iron is
highly reactive and may react unspecifically with all
structures of cells inducing damage of DNA and
proteins. It has previously been noted that the viability
of Jurkat cells can be decreased by oxidative DNA
damage in cells caused by hydroxyl radicals generated
in the Fenton reaction (Riviere et al. 2006; Tenopou-
lou et al. 2005).
The comparison of the effect of ferrous iron and
hydrogen peroxide on activity of recombinant CD45,
LAR and PTP1B showed that the impact of ferrous
was concentration and phosphatase dependent. The
addition of higher concentrations of ferrous iron to
hydrogen peroxide led to increase of inactivation,
especially of PTP1B phosphatase.
Although the electrostatic potential on a surface of
active sites is similar for CD45, LAR and PTP1B and
largely positively charged, there are many differences
in a structural surface of those phosphatases (Barr et al.
2009). The diverse regions include the topology of
Fig. 6 Schematic representation of the proposed mechanism of
hydrogen peroxide inactivation of PTP CD45, possible electro-
static repulsion of ferrous iron (II) and unspecific damage
caused by hydroxyl radical formed in Fenton reaction
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second binding site, contributing to substrate speci-
ficity and may explain slight differences in sensitivity
of selected phosphatases. The higher vulnerability of
PTP1B may be due to possible allosteric regulation of
the activity of PTP1B. It was found that small-
molecule inhibitors may bind in a allosteric binding
site of PTP1B located 20 A˚ from the active site
(Tabernero et al. 2008) and do not have negative
charges (Zhang and Zhang 2007). Allosteric inhibition
blocks the mobility of catalytic WPD-loop and stabi-
lize the inactive conformation of PTP1B (Wiesmann
et al. 2004; Hansan et al. 2005). Previous crystallo-
graphic studies have shown that PTP1B can exist in
two conformations. In the native form, the WPD-loop
is in an ‘‘open’’ conformation, and the binding pocket
is easily accessible to substrate. Upon substrate
binding, the WPD-loop closes over the active site,
forming a tight binding pocket for the substrate
(Barford et al. 1994; Jia et al. 1995). The WPD-loop
closure is essential for the catalytic mechanism of
PTP1B (Kolmodin and Aqvist 2001). Unlike catalytic
site, the allosteric site is not well conserved and
substantially less polar. The allosteric binding site of
PTP1B possessing neutral surface is presented in
Fig. 7, with Phe250 and Ser295 residues. The presence
of secondary binding pocket can be one of possible
explanation for the small differences in inhibitory
level.
In conclusion, hydrogen peroxide produced upon
activation of many cell surface receptors is considered
as a major regulator of PTPs in biological systems.
Here, we demonstrate that ferrous iron (II) may be
considered as inhibitor of PTPs. In this studies, we
present how different concentration of iron may alter
inhibitory effect of hydrogen peroxide. We also
propose that probably electrostatic potential of pro-
teins surface protects enzymes from the chemistry of
elements present in the surrounding environment.
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